[
  {
    "ts": null,
    "headline": "Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",
    "summary": "Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.",
    "url": "https://finnhub.io/api/news?id=55d1529df95faa211f30c69c3af5c9bc27914aaccba3736ed4c24b15134a2681",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734134056,
      "headline": "Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",
      "id": 131977467,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445810162/image_1445810162.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.",
      "url": "https://finnhub.io/api/news?id=55d1529df95faa211f30c69c3af5c9bc27914aaccba3736ed4c24b15134a2681"
    }
  },
  {
    "ts": null,
    "headline": "Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst",
    "summary": "BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and biotech companies dropped after pandemic-related overspending, and demand in China stayed weak. This led some Life Sciences companies to lower their already-conservative fiscal year revenue forecasts as the year progressed. For most of fiscal year 2024, Life Sciences company valuations remained higher than pre-COVID levels but declined after the U.S. elections. Looking ahead",
    "url": "https://finnhub.io/api/news?id=72e3558ded082231b62edd08ccd8da4257362093ac0c732c35e6d0d3666f7f0a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734116244,
      "headline": "Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst",
      "id": 131977555,
      "image": "https://media.zenfs.com/en/Benzinga/d340fe96fb6e0ba350207d6be38ae4ff",
      "related": "DHR",
      "source": "Yahoo",
      "summary": "BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and biotech companies dropped after pandemic-related overspending, and demand in China stayed weak. This led some Life Sciences companies to lower their already-conservative fiscal year revenue forecasts as the year progressed. For most of fiscal year 2024, Life Sciences company valuations remained higher than pre-COVID levels but declined after the U.S. elections. Looking ahead",
      "url": "https://finnhub.io/api/news?id=72e3558ded082231b62edd08ccd8da4257362093ac0c732c35e6d0d3666f7f0a"
    }
  },
  {
    "ts": null,
    "headline": "Danaher Corp. stock rises Friday, outperforms market",
    "summary": "Danaher Corp. stock rises Friday, outperforms market",
    "url": "https://finnhub.io/api/news?id=46ebe1f6a063c9073de0275cd289d8f316108cd456b590e461239ec4110c41ca",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734107880,
      "headline": "Danaher Corp. stock rises Friday, outperforms market",
      "id": 132066601,
      "image": "",
      "related": "DHR",
      "source": "MarketWatch",
      "summary": "Danaher Corp. stock rises Friday, outperforms market",
      "url": "https://finnhub.io/api/news?id=46ebe1f6a063c9073de0275cd289d8f316108cd456b590e461239ec4110c41ca"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher: The Cycle Has Already Turned Around",
    "summary": "Thermo Fisher stock is a buy with signs of recovery and potential growth, backed by positive sales and margins. Read an analysis of TMO stock here.",
    "url": "https://finnhub.io/api/news?id=1111b31adf1daa8c29b73c3b9f5be9cd083e7972f5974267cc096356d5aba552",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734063747,
      "headline": "Thermo Fisher: The Cycle Has Already Turned Around",
      "id": 131961931,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1585548490/image_1585548490.jpg?io=getty-c-w1536",
      "related": "DHR",
      "source": "SeekingAlpha",
      "summary": "Thermo Fisher stock is a buy with signs of recovery and potential growth, backed by positive sales and margins. Read an analysis of TMO stock here.",
      "url": "https://finnhub.io/api/news?id=1111b31adf1daa8c29b73c3b9f5be9cd083e7972f5974267cc096356d5aba552"
    }
  }
]